Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced bone loss.

P Tannirandorn1, S Epstein

  • 1Division of Endocrinology, Diabetes and Metabolism, Hospital of theUniversity of Pennsylvania, Philadelphia, USA.

Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age-related maximal heart rate: examination and refinement of prediction equations.

The Journal of sports medicine and physical fitness·2014
Same author

Staphylococcal resistance to ristocetin, oleandomycin, and novobiocin.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

Special Care: a continuation of growth.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·2013
Same author

Tools in the assessment of sarcopenia.

Calcified tissue international·2013
Same author

What is Responsible for the Rise in Lung Cancer Mortality?

New solutions : a journal of environmental and occupational health policy : NS·2012
Same author

Does plasma IGF-BP3 measurement contribute to the diagnosis of growth hormone deficiency in children?

Annales d'endocrinologie·2011
Same journal

Correction to: Melatonin at pharmacological concentrations suppresses osteoclastogenesis via the attenuation of intracellular ROS.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same journal

Letter to the Editor: multiplicity, microbiome interventions, and measurement biases in bone health biomarkers.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same journal

Association between myosteatosis and bone mineral density in postmenopausal women.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same journal

Author response to the letter to the editor regarding "Hip Response to Romosozumab in Glucocorticoid Users: Beyond Systemic Bone Turnover Markers".

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same journal

Preventing post-denosumab bone loss with zoledronate: a 2-year randomized trial in post-menopausal women without and with pre-exposure to bisphosphonates.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same journal

Revisiting the Osteoporosis Self-Assessment Tool (OST): evidence from a multi-cohort study in Asia supporting age-dependent thresholds.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
See all related articles

Certain medications can cause bone loss and osteoporosis, even in young adults. Physicians must be aware of these drug-induced risks and monitor patients to prevent bone damage.

Area of Science:

  • Endocrinology
  • Pharmacology
  • Bone Biology

Background:

  • Osteoporosis is common in postmenopausal women and the elderly.
  • Risk factors include genetics, lifestyle, and deficiencies, but drug-induced bone loss is often overlooked.
  • Certain medications can lead to significant bone loss in individuals without other predisposing factors.

Purpose of the Study:

  • To review the pathophysiology and mechanisms of drug-induced bone loss.
  • To discuss treatment strategies for medication-related osteoporosis and osteomalacia.
  • To emphasize physician awareness and monitoring for preventable bone loss.

Main Methods:

  • Literature review of drug-induced bone loss mechanisms.
  • Analysis of common medications associated with bone loss.

Related Experiment Videos

  • Discussion of diagnostic and therapeutic approaches.

    • Main Results:

    • Extensive list of drugs identified as causes of bone loss (e.g., glucocorticoids, LHRH agonists, anti-seizure drugs).
    • Mechanisms include interference with bone remodeling and nutrient absorption.
    • Osteoporosis and osteomalacia are key outcomes of drug-induced bone loss.

    Conclusions:

    • Drug-induced bone loss is a significant and preventable issue.
    • Physician awareness, careful prescribing, and monitoring are crucial.
    • Timely intervention can preserve bone health in patients on bone-losing medications.